Actinium Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

악티늄 파머슈티컬스NYSEAMERICAN:ATNM · NYSE Amex · Healthcare · sector #17

$1.11-7.50%

2026-10-06 close

Actinium Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$42M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy